Applied multiplex allele specific PCR to detect second-line drug resistance among multidrug-resistant tuberculosis in China - 22/11/17
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
Abstract |
Rapid detection of resistance to the second-line drugs is essential for early initiation of appropriate anti-tubercular treatment regimen among multi-drug tuberculosis (MDR-TB). In this study, we applied a multiplex allele-specific PCR (MAS-PCR) to identify the mutations on codons 90 and 94 of gyrA and nucleotide 1401 of rrs for detecting ofloxacin (OFX) and kanamycin (KAN) resistance in 139 MDR-TB isolates from China. Using the traditional phenotypic method as the reference, MAS-PCR detected resistance to OFX and KAN with sensitivities of 67.3% and 76.5%, respectively, and specificities of 100.0%. Therefore, MAS-PCR assays can be used for rapid detection of second-line drug resistance among MDR-TB in China, enabling early administration of appropriate treatment regimens to the affected MDR-TB patients.
Le texte complet de cet article est disponible en PDF.Keywords : Multiplex allele specific PCR, Multidrug-resistant tuberculosis, Ofloxacin, Kanamycin
Plan
Vol 107
P. 1-4 - décembre 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?